201855 U.S. healthcare in black, white and shades of brown: Racial and ethnic disparities in utilization among privately insured U.S. adults

Monday, November 9, 2009: 11:00 AM

Kimberly Enard, MBA, MSHA , Department of Health Services, University of California, Los Angeles, Los Angeles, CA
As policy makers evaluate health system reforms designed to expand health insurance coverage in the U.S., questions remain as to whether increased coverage will result in equitable, effective and efficient access to care. The objective of this study was to examine racial/ethnic inequities, or disparities, in healthcare access as measured by annual outpatient (OP) visits, charges and expenditures among U.S. adults aged 24-64 years continuously covered by private insurance. The study population included Medical Expenditure Panel Survey respondents from 2005 and 2006, classified by race (white, black, Asian/Pacific Islander) and ethnicity (non-Hispanic and Hispanic). Race and ethnicity were not mutually exclusive. Multivariate analyses were conducted using a two-part model with logistic regression to estimate unconditional outcomes (likelihood of any visits, charges or expenditures) and ordinary least squares regression to estimate conditional outcomes (amount of visits, charges or expenditures, conditional on any utilization having occurred). Relative risks (RR) by race/ethnicity were also estimated for each outcome. The study controlled for covariates including age, gender, marital status, family size, education, income, usual source of care, health status and morbidities. The results indicate that, even among adults continuously covered by private insurance during the reporting period, race/ethnicity appeared to be significantly associated with reduced probabilities of having any OP visits, charges or expenditures and with reduced amounts of OP service utilization. The findings confirm previous studies demonstrating that racial/ethnic disparities persist even among insured populations, but also indicate that insurance continuity and type (private v. public) may not sufficiently overcome racial/ethnic healthcare barriers.

Learning Objectives:
1. Describe features of equitable and inequitable access to healthcare 2. Compare racial/ethnic differences in access to outpatient healthcare 3. Discuss initiatives to be considered by healthcare providers, payers and policy-makers interested in reducing racial/ethnic disparities in healthcare access

Keywords: Health Care Access, Insurance-Related Barriers

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a healthcare professional with more than eight years of experience in management, marketing, planning/business development and consulting primarily in the hospital industry. I also have more than seven years of experience as a professional journalist. I have earned an MBA and Master of Science in Health Administration (MSHA), and I am a Fellow in the American College of Healthcare Executives. I am currently a PhD student at the University of California, Los Angeles, with research interests that include the role of perceived and actual bias, stereotyping and discrimination on healthcare behaviors, access and outcomes; the effect of insurance status, type and continuity on healthcare access and quality among vulnerable populations; and research and policy development in the area of community contextual factors, with an emphasis on exploring the role of public-private partnerships in improving access and quality for vulnerable populations. I have conducted two previous studies using Medical Expenditure Panel Survey (MEPS) data, and am currently using MEPS confidential, non-public use data files to complete my dissertation project, Exit the Hospital: The Effect of Race and Hispanic Origin on Health Care Access and Quality in the Years Following Community Hospital Closures.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.